Cover Page
Cover Page | Nov. 20, 2024 |
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Nov. 20, 2024 |
Entity Registrant Name | Cidara Therapeutics, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-36912 |
Entity Tax Identification Number | 46-1537286 |
Entity Address, Address Line One | 6310 Nancy Ridge Drive, |
Entity Address, Address Line Two | Suite 101 |
Entity Address, City or Town | San Diego, |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92121 |
City Area Code | 858 |
Local Phone Number | 752-6170 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, Par Value $0.0001 Per Share |
Trading Symbol | CDTX |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001610618 |
Amendment Flag | false |